AI assistant
FMC CORP — Director's Dealing 2017
May 18, 2017
31144_dirs_2017-05-18_980f9b3a-4cb7-41f6-a5e1-7e4fd339fb2b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FMC CORP (FMC)
CIK: 0000037785
Period of Report: 2017-05-16
Reporting Person: Norris Eric (President Health Nutrition)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-16 | Common Stock | M | 2642 | $40.885 | Acquired | 28750 | Direct |
| 2017-05-16 | Common Stock | M | 2484 | $47.595 | Acquired | 31234 | Direct |
| 2017-05-16 | Common Stock | M | 3444 | $59.47 | Acquired | 34678 | Direct |
| 2017-05-16 | Common Stock | S | 2642 | $75.961 | Disposed | 32036 | Direct |
| 2017-05-16 | Common Stock | S | 2484 | $75.953 | Disposed | 29552 | Direct |
| 2017-05-16 | Common Stock | S | 3444 | $75.958 | Disposed | 26108 | Direct |
| 2017-05-16 | Common Stock | S | 1494 | $75.839 | Disposed | 24614 | Direct |
| 2017-05-17 | Common Stock | S | 1294 | $74.25 | Disposed | 23320 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-16 | Stock Option (Right to Buy) | $40.89 | M | 2642 | Disposed | 2021-02-17 | Common Stock (2642) | Direct |
| 2017-05-16 | Stock Option (Right to Buy) | $47.60 | M | 2484 | Disposed | 2022-02-16 | Common Stock (2484) | Direct |
| 2017-05-16 | Stock Option (Right to Buy) | $59.47 | M | 3444 | Disposed | 2023-02-18 | Common Stock (3444) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6288.437 | Indirect |
Footnotes
F1: Represents the weighted average sales price for price increments ranging from $75.951 to $75.968. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
F2: Represents the weighted average sales price for price increments ranging from $75.950 to $75.960. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
F3: Represents the weighted average sales price for price increments ranging from $75.826 to $75.871. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
F4: Based on plan statement as of May 16, 2017.